PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Actavis Pharma ×

UPDATED
Regulatorische Updates
17. Sept. 2026•1 Min. Lesezeit
FDA Approves Griseofulvin Oral Suspension (ANDA 065394)
The FDA has approved an oral suspension of griseofulvin (125 mg/5 mL) from Actavis Pharma under ANDA 065394.
1
UPDATED
Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
FDA Approves Levetiracetam Oral Solution (ANDA078976)
FDA has approved ANDA078976 for Levetiracetam oral solution, a prescription drug manufactured by Actavis Pharma, Inc., with a detailed submission history.